NC
AMGN icon

Northpointe Capital’s Amgen AMGN Stock Holding History

Northpointe Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,963
Closed -$1.65M – 170
2018
Q2 		$1.65M Sell
8,963
-10,201
-53% -$1.8M 0.22% 162
2018
Q1 		$3.27M Buy
+19,164
New +$3.52M 0.41% 101
2016
Q2 		– Sell
-500
Closed -$75K – 194
2016
Q1 		$75K Buy
+500
New +$74.3K 0.01% 229

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northpointe Capital's AMGN Position: Q3 2018 in Review

Northpointe Capital sold out of Amgen (AMGN) in Q3 2018, closing a stake of 8,963 shares — an estimated $1.65M sold.

Northpointe Capital first reported a position in AMGN in Q1 2016 and held it in 3 quarters. The position peaked at $3.27M in Q1 2018. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Northpointe Capital reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
  • Northpointe Capital sold 8,963 Amgen shares in Q3 2018, an estimated $1.65M.
  • Northpointe Capital first reported a position in Amgen in Q1 2016 and held it in 3 quarters.
  • Northpointe Capital's Amgen position peaked at $3.27M in Q1 2018.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Northpointe Capital's 13F filing for Q3 2018, filed 25 Oct 2018.